Company / Cost of Revenue
ENvue Medical, Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.1M
FY2025
5-year range
$409.0K / $1.1M
FY2021-FY2025
Trend
+40.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $585,000 to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +33.4%.
Increased from $585,000 to $1M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +4.3%
- 5-Year CAGR
- +33.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +33.4%, indicating consistent growth.
- In FY2025, cost of revenue increased 40.8% year-over-year.
- Lowest cost of revenue in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | +40.8% |
| FY2024 | $746.0K | +27.5% |
| FY2023 | $585.0K | -36.8% |
| FY2022 | $925.0K | +126.2% |
| FY2021 | $409.0K | +64.3% |
| FY2020 | $249.0K | +57.6% |
| FY2019 | $158.0K | +79.5% |
| FY2018 | $88.0K | +0.0% |
| FY2017 | $88.0K | +79.6% |
| FY2016 | $49.0K | -47.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026